These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31619516)

  • 1. Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.
    MacLachlan BJ; Dolton G; Papakyriakou A; Greenshields-Watson A; Mason GH; Schauenburg A; Besneux M; Szomolay B; Elliott T; Sewell AK; Gallimore A; Rizkallah P; Cole DK; Godkin A
    J Biol Chem; 2019 Dec; 294(52):20246-20258. PubMed ID: 31619516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4
    Hulin-Curtis S; Geary JK; MacLachlan BJ; Altmann DM; Baillon L; Cole DK; Greenshields-Watson A; Hesketh SJ; Humphreys IR; Jones IM; Lauder SN; Mason GH; Smart K; Scourfield DO; Scott J; Sukhova K; Stanton RJ; Wall A; Rizkallah PJ; Barclay WS; Gallimore A; Godkin A
    Cell Rep; 2024 Jun; 43(6):114259. PubMed ID: 38819988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4
    Greenshields-Watson A; Attaf M; MacLachlan BJ; Whalley T; Rius C; Wall A; Lloyd A; Hughes H; Strange KE; Mason GH; Schauenburg AJ; Hulin-Curtis SL; Geary J; Chen Y; Lauder SN; Smart K; Vijaykrishna D; Grau ML; Shugay M; Andrews R; Dolton G; Rizkallah PJ; Gallimore AM; Sewell AK; Godkin AJ; Cole DK
    Cell Rep; 2020 Jul; 32(2):107885. PubMed ID: 32668259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells.
    Li Y; Depontieu FR; Sidney J; Salay TM; Engelhard VH; Hunt DF; Sette A; Topalian SL; Mariuzza RA
    J Mol Biol; 2010 Jun; 399(4):596-603. PubMed ID: 20417641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
    Murthy VL; Stern LJ
    Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex.
    Wang XX; Li Y; Yin Y; Mo M; Wang Q; Gao W; Wang L; Mariuzza RA
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15960-5. PubMed ID: 21900604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition.
    Szeto C; Bloom JI; Sloane H; Lobos CA; Fodor J; Jayasinghe D; Chatzileontiadou DSM; Grant EJ; Buckle AM; Gras S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
    Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
    J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ADAMTS13
    Gilardin L; Delignat S; Peyron I; Ing M; Lone YC; Gangadharan B; Michard B; Kherabi Y; Sharma M; Pashov A; Latouche JB; Hamieh M; Toutirais O; Loiseau P; Galicier L; Veyradier A; Kaveri S; Maillère B; Coppo P; Lacroix-Desmazes S
    Haematologica; 2017 Nov; 102(11):1833-1841. PubMed ID: 28751567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.
    Poluektov YO; Kim A; Hartman IZ; Sadegh-Nasseri S
    PLoS One; 2013; 8(8):e71228. PubMed ID: 23951115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimers.
    Holland CJ; Rizkallah PJ; Vollers S; Calvo-Calle JM; Madura F; Fuller A; Sewell AK; Stern LJ; Godkin A; Cole DK
    Sci Rep; 2012; 2():629. PubMed ID: 22953050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
    J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
    Schulze MS; Anders AK; Sethi DK; Call MJ
    PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.
    Knapp B; Fischer G; Van Hemelen D; Fae I; Maillere B; Ebner C; Schreiner W; Bohle B; Jahn-Schmid B
    BMC Immunol; 2012 Aug; 13():43. PubMed ID: 22871092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
    Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
    PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model.
    Knapp B; Omasits U; Bohle B; Maillere B; Ebner C; Schreiner W; Jahn-Schmid B
    Mol Immunol; 2009 May; 46(8-9):1839-44. PubMed ID: 19232439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.